Anika Therapeutics, Inc. (ANIK)
21.53
+0.42
(+1.99%)
USD |
NASDAQ |
Sep 02, 14:17
Anika Therapeutics Free Cash Flow : 0.562M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.562M |
| March 31, 2026 | 1.039M |
| December 31, 2025 | 4.362M |
| September 30, 2025 | 0.648M |
| June 30, 2025 | -1.135M |
| March 31, 2025 | -3.951M |
| December 31, 2024 | -2.931M |
| September 30, 2024 | -1.408M |
| June 30, 2024 | 1.136M |
| March 31, 2024 | -4.142M |
| December 31, 2023 | -7.215M |
| September 30, 2023 | -11.06M |
| June 30, 2023 | -15.79M |
| March 31, 2023 | -4.889M |
| December 31, 2022 | -3.077M |
| September 30, 2022 | 2.316M |
| June 30, 2022 | 2.076M |
| March 31, 2022 | 2.907M |
| December 31, 2021 | 3.254M |
| September 30, 2021 | 2.047M |
| June 30, 2021 | 6.863M |
| March 31, 2021 | 8.267M |
| December 31, 2020 | 11.44M |
| September 30, 2020 | 22.05M |
| June 30, 2020 | 26.08M |
| Date | Value |
|---|---|
| March 31, 2020 | 27.07M |
| December 31, 2019 | 34.18M |
| September 30, 2019 | 31.27M |
| June 30, 2019 | 31.28M |
| March 31, 2019 | 30.64M |
| December 31, 2018 | 30.26M |
| September 30, 2018 | 24.92M |
| June 30, 2018 | 24.80M |
| March 31, 2018 | 25.10M |
| December 31, 2017 | 31.83M |
| September 30, 2017 | 31.76M |
| June 30, 2017 | 30.83M |
| March 31, 2017 | 22.31M |
| December 31, 2016 | 9.787M |
| September 30, 2016 | 13.43M |
| June 30, 2016 | 12.86M |
| March 31, 2016 | 27.37M |
| December 31, 2015 | 29.84M |
| September 30, 2015 | 35.89M |
| June 30, 2015 | 32.53M |
| March 31, 2015 | 28.83M |
| December 31, 2014 | 38.43M |
| September 30, 2014 | 32.10M |
| June 30, 2014 | 34.84M |
| March 31, 2014 | 32.01M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Perspective Therapeutics, Inc. | -121.38M |
| MiMedx Group, Inc. | 42.33M |
| ABVC BioPharma, Inc. | -2.697M |
| Enovis Corp. | 63.66M |
| Edwards Lifesciences Corp. | 1.434B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.684M |
| Cash from Investing (Quarterly) | -1.28M |
| Cash from Financing (Quarterly) | -0.701M |
| Free Cash Flow Per Share (Quarterly) | -0.1555 |
| Free Cash Flow to Equity (Quarterly) | -1.647M |
| Free Cash Flow to Firm (Quarterly) | -2.133M |
| Free Cash Flow Yield | 0.19% |